EICHORPublic-registry site landscape for NCT03394677, “Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis”, a Atopic Dermatitis study sponsored by Dermavant Sciences GmbH. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03394677 (registry record) |
| Study title | Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis |
| Official title | Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerabililty of RVT-501 Topical Ointment in Pediatric Patients With Mild to Moderate Atopic Dermatitis |
| Sponsor | Dermavant Sciences GmbH |
| Condition(s) | Atopic Dermatitis |
| Phase | PHASE2 |
| Listed sites | 7 |
| Intervention(s) | RVT-501 0.5% ointment, Vehicle ointment |
| Site countries | United States, Canada |
Patient-friendly overview of this study: eichor.com/study/NCT03394677.
Eichor generates a preliminary site-risk snapshot for NCT03394677 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
